Security of supply is a central element in our brand promise to our customers: Quality, Reliability and Sustainability. Our multi-supplier strategy ensures we are not dependent on a single source for our raw materials and intermediates. Furthermore, our production is largely backward-integrated. This generates efficiencies in our production and allows us greater control over our supply chain.

Centrient remains one of the last remaining manufacturers of certain compounds such as base Penicillin G in the western hemisphere. We continue to invest in the growth of our antibiotics manufacturing. Recently, this has involved increasing capacity at our landmark 7-ADCA antibiotic intermediate facility in Delft, the Netherlands. With this investment, we aim to meet the growing demand for sustainably produced 7-ADCA, the key intermediate for cephalosporin APIs.